Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative positron emission tomography (PET) radiopharmaceuticals, today announced results ...
A phase I/II study of the investigational drug alisertib in combination with abiraterone and prednisone (AP) for patients with metastatic castration-resistant prostate cancer (mCRPC) progressing on ...
The effect of pathologic T-stage and Gleason score on cancer-specific survival in patients with positive surgical margins after surgery for high-risk prostate cancer. This is an ASCO Meeting Abstract ...
Incontinence and other urinary problems after prostate cancer treatment can be eased with Kegel exercises, bladder training, ...
Up to 10% of men will experience some degree of urinary incontinence (involuntary leakage of urine) after prostate cancer surgery. "It occurs because part of the continence mechanism may have to be ...
Experiencing an overactive bladder (OAB) is common after undergoing prostate surgery. Various treatment options exist to help manage the condition and reduce the frequent urge to urinate. OAB refers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results